Acarix omslagsbild
Acarix

Acarix

Medicinsk utrustning

Malmö, Skane County 3 767 följare

Revolutionizing cardiac diagnostics with the CADScor®System, an AI-driven tool for rapid and non-invasive CAD detection.

Om oss

Acarix is a pioneering Swedish medical device company, with an expanding presence in the U.S., transforming cardiac diagnostics with AI-powered acoustic technology. Our flagship solution, the CADScor® System, can rapidly and non-invasively risk stratify Coronary Artery Disease, helping physicians confidently assess chest pain patients while reducing unnecessary, costly, and invasive procedures. With CE-mark approval and FDA De Novo clearance, the CADScor®System provides a patient-specific CAD-score with 96% confidence, streamlining decision-making in both primary and specialized care. Backed by innovation and clinical validation, Acarix is committed to optimizing healthcare efficiency and improving patient care. Acarix is listed on the Nasdaq First North Premier Growth Market in Stockholm (ticker: ACARIX) and cross-traded on the OTCQB market in the U.S. (ticker: ACIXF).

Webbplats
http://www.acarix.com
Bransch
Medicinsk utrustning
Företagsstorlek
11–50 anställda
Huvudkontor
Malmö, Skane County
Typ
Publikt aktiebolag
Grundat
2009
Specialistområden
Acoustics, Stable Chestpain, Coronary Artery Disease, CAD och Diagnostic Aid

Adresser

Anställda på Acarix

Uppdateringar

Liknande sidor

Finansiering

Acarix 3 rundor totalt

Senaste finansieringsrunda

Okänd serie
Se mer info på crunchbase